GHK-Cu 150 mg pen
Also known as · Astranordic GHK-Cu Pen
High-dose GHK-Cu pen from Astranordic. 1.5× the dose of the standard 100 mg vial, in a pre-filled research pen.
Chemistry quick-facts
- CAS
- 89030-95-5
- Formula
- C14H24CuN6O4
- MW
- 403.9 Da
- Length
- 3 aa
- Status
- Cosmetic-approved ingredient (EU, US). No therapeutic approval.
- Purity (HPLC)
- ≥ 99.6%
Mechanism of action
As per GHK-Cu 100 mg — transcriptomic modulation and SOD-mimetic activity.
Research context
Pre-filled pen format of the copper tripeptide complex. The Astranordic pen series matches the clinical-grade pen devices used in investigational-peptide research.
Published studies
A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.
Reconstitution
- Solvent
- Pre-reconstituted
- Typical volume
- N/A
- · Cold-chain shipped. Protect from light.
Storage
- Lyophilised
- Pre-filled pen — store 2–8 °C. Pen is shipped cold-chain; after first use it may be kept at 2–8 °C.
- Reconstituted
- Pens are pre-reconstituted. Once opened, use within the manufacturer-stated window (typically 4 weeks refrigerated).
- Shelf life — sealed
- See pen label — typically 18–24 months sealed under refrigeration.
FAQ
Why choose the pen over the vial?+
Researchers running longer in vitro time-course work prefer the pen for consistency of measurement. Identical peptide; different presentation.
This page summarises the research literature on GHK-Cu 150 mg pen for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.
- ResearchGHK-Cu 100 mg
Copper-bound tripeptide. Deep-blue lyophilised cake — the visual signature of intact Cu²⁺ coordination.
- ResearchGlow Blend 140 mg pen
High-dose pre-filled pen version of the Glow dermal blend. 2× the dose of the standard vial kit.
- ResearchGlow Blend 70 mg
ChemAesthetic's multi-peptide dermal blend. Combines GHK-Cu with complementary signalling peptides commonly co-studied in dermal-regeneration research
- Biomarkerhs-CRP 2.5 mg/L
High-sensitivity C-reactive protein at 2.5 mg/L sits in the 'intermediate cardiovascular risk' category most cardiology research uses. What it measures, what drives it, and how to interpret your number.
- ComparisonGHK-Cu vs generic "copper peptides" — what's actually in the bottle
Most products marketed as "copper peptides" contain GHK-Cu specifically — but not all. The research literature on GHK-Cu is far ahead of any other copper-peptide complex.
- ComparisonGHK-Cu injectable vs topical — what the research literature shows
GHK-Cu research splits between injectable (subcutaneous) and topical (cosmetic / wound-healing) routes. Different penetration, different research applications.